These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 37178491

  • 21. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: A propensity score matching analysis.
    Feng H, Yang C, Xu F, Zhao Y, Jin T, Wei Z, Wang D, Dai C.
    Eur J Surg Oncol; 2022 Feb; 48(2):418-424. PubMed ID: 34509336
    [Abstract] [Full Text] [Related]

  • 22. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
    Lee KF, Wong J, Hui JW, Cheung YS, Chong CC, Fong AK, Yu SC, Lai PB.
    Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
    [Abstract] [Full Text] [Related]

  • 23. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).
    Santambrogio R, Chiang J, Barabino M, Meloni FM, Bertolini E, Melchiorre F, Opocher E.
    Ann Surg Oncol; 2017 Jan; 24(1):257-263. PubMed ID: 27581608
    [Abstract] [Full Text] [Related]

  • 24. The (Eternal) Debate on Microwave Ablation Versus Radiofrequency Ablation in BCLC-A Hepatocellular Carcinoma.
    Ricci AD, Rizzo A, Bonucci C, Tavolari S, Palloni A, Frega G, Mollica V, Tober N, Mazzotta E, Felicani C, Serra C, Brandi G.
    In Vivo; 2020 Jan; 34(6):3421-3429. PubMed ID: 33144450
    [Abstract] [Full Text] [Related]

  • 25. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
    Aarts BM, Gomez FM, Lopez-Yurda M, Bevers RFM, Herndriks J, Beets-Tan RGH, Bex A, Klompenhouwer EG, van der Meer RW.
    Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
    [Abstract] [Full Text] [Related]

  • 26. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis.
    Zhang C, Gao R, Guo S, Ning C, Li A, Wang X, Li S, Ding J, Kong X, Wang Q, Xu Y, Li J, Gao J, Wang S, Kong J, Ke S, Sun W.
    Eur J Radiol; 2022 Oct; 155():110498. PubMed ID: 36049409
    [Abstract] [Full Text] [Related]

  • 27. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
    Yu H, Zhao F, Men X, Zhu H, Yan J, Liu Z, Liu Q, Feng Y, Wang L, Meng M, Zhu Q, Zhao X.
    Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
    [Abstract] [Full Text] [Related]

  • 28. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis.
    Han J, Fan YC, Wang K.
    Medicine (Baltimore); 2020 Oct 23; 99(43):e22703. PubMed ID: 33120763
    [Abstract] [Full Text] [Related]

  • 29. Transarterial chemoembolization combined with microwave ablation and apatinib in patients with Barcelona clinic liver cancer Stage C hepatocellular carcinoma: A propensity score matching analysis.
    Shuanggang C, Shen L, Qiu Z, Qi H, Cao F, Xie L, Fan W.
    J Cancer Res Ther; 2020 Oct 23; 16(2):250-257. PubMed ID: 32474509
    [Abstract] [Full Text] [Related]

  • 30. Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis.
    Tong Y, Cai R, Li JX, Chang DH, Wang LZ, Cai WW, Xiao YD.
    Aliment Pharmacol Ther; 2022 Dec 23; 56(11-12):1602-1614. PubMed ID: 36285593
    [Abstract] [Full Text] [Related]

  • 31. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH, Ho CM, Wu CH, Liang PC, Wu YM, Hu RH, Lee PH, Ho MC.
    Surg Endosc; 2020 Dec 23; 34(12):5566-5573. PubMed ID: 31993821
    [Abstract] [Full Text] [Related]

  • 32. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P, Zhang Z, Kuai J.
    J BUON; 2019 Dec 23; 24(1):163-170. PubMed ID: 30941966
    [Abstract] [Full Text] [Related]

  • 33. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Gupta P, Maralakunte M, Kumar-M P, Chandel K, Chaluvashetty SB, Bhujade H, Kalra N, Sandhu MS.
    Eur Radiol; 2021 Jul 23; 31(7):5400-5408. PubMed ID: 33439319
    [Abstract] [Full Text] [Related]

  • 34. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W, Deng Q, Lin S, Wang Y, Xu G.
    Int J Hyperthermia; 2019 Jul 23; 36(1):264-272. PubMed ID: 30676100
    [Abstract] [Full Text] [Related]

  • 35. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm.
    Zheng H, Xu C, Wang X, Li J, Zhao X, Qi J, Feng Y, Zhu Q.
    Int J Hyperthermia; 2020 Nov 12; 37(1):1345-1353. PubMed ID: 33289415
    [Abstract] [Full Text] [Related]

  • 36. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
    Hu H, Chi JC, Liu R, Zhai B.
    Int J Hyperthermia; 2021 Nov 12; 38(1):191-201. PubMed ID: 33682598
    [Abstract] [Full Text] [Related]

  • 37. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
    Yu Q, Liu C, Navuluri R, Ahmed O.
    Abdom Radiol (NY); 2021 Sep 12; 46(9):4467-4475. PubMed ID: 33870454
    [Abstract] [Full Text] [Related]

  • 38. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC, Chen PH, Yeh JH, Hsiao P, Lo GH, Tan T, Cheng PN, Lin HY, Chen YS, Hsieh KC, Hsieh PM, Lin CW.
    BMC Gastroenterol; 2021 Nov 08; 21(1):418. PubMed ID: 34749663
    [Abstract] [Full Text] [Related]

  • 39. Risk factors for recurrence beyond Milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma.
    Chu W, Li P, Wu X, Zhang P, Zhou H, Niu B.
    Rev Esp Enferm Dig; 2022 Oct 08; 114(10):580-585. PubMed ID: 35042367
    [Abstract] [Full Text] [Related]

  • 40. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy.
    Miyamoto N, Kanaya M, Fujii T, Kato H, Kudo K, Kinota N.
    Jpn J Radiol; 2021 Apr 08; 39(4):376-386. PubMed ID: 33150469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.